EnviroTech :: Biotech
Lonza Signs Manufacturing Deal with French Biopharma Firm
11:49 PM MDT | July 14, 2009 | Deepti Ramesh
Lonza says it has signed an agreement with biopharmaceutical company LFB (Les Ulis, France) to manufacture a monoclonal anti-RhD antibody developed by LFB. The process developed by LFB will be transferred to Lonza which will provide manufacturing services for supporting the phase III clinical program, under the deal. Lonza will also support LFB in its regulatory submissions by providing appropriate documentation. Financial details of the agreement were not disclosed. LFB is the leading manufacturer of plasma-derived medicinal products in France and sixth...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee